Cardiac Rhythm Management Market Analysis, Size, Trends | Global | 2016-2022 | MedSuite

Cardiac Rhythm Management Market Analysis, Size, Trends | Global | 2016-2022 | MedSuite

0

  • Year: 2016
  • Scope: 2012-2022
  • Region: Asia-Pacific, Europe, United States
  • Published Date: 11/04/2015
  • Pages: 920
  • Type: MedSuite

Industry Trends

The global cardiac rhythm management market is expected to experience growth across all product segments over the forecast period. The more recent products are expected to experience strong growth on a percentage basis but not on an absolute unit or market growth basis simply because newer devices take a while for physicians to adopt. Also, considering the criticality of the procedures, it will take years of practice before a device can fully take off. Therefore, most of the devices sold for newer market segments will go towards training and clinical studies. Throughout the forecast period, replacement devices are expected to experience strong growth, which limits the full growth potential of the market. However, there is a noticeable shift from single chamber devices to dual chamber devices that will drive many of the CRM market segments throughout the forecast period.

Over the forecast period, the cardiac rhythm management market will be driven by the aging population and adoption of advanced CRM devices. In the newer markets, particularly leadless pacemakers and subcutaneous ICDs (S-ICDs), continued education is critical to increase cardiologists’ confidence in these types of cardiac devices. Most importantly, since the CRM market is dominated by large players and is quite a mature market, the responsibility lies on the market leaders to convince physicians that new device functionalities are required to improve the overall effectiveness of cardiac procedures.

Report Regional Coverage

Throughout this research series, iData has covered several countries in great detail. Each country may be purchased as a stand-alone report, tailoring the data to your needs. The covered countries are:

    • United States
    • Europe (5 countries including: Germany, France, U.K., Italy and Spain)
    • Asia-Pacific

The Only Medical Device Market Research With:

Unit Sales Growth Analysis
Average Selling Prices
Competitor Shares by Segment & Country
 SKU-Level Research Methods
 The Lowest Acquisition Cost

Highly Detailed Segmentation

While this report suite contains all applicable cardiac rhythm management market data, each of the market segments are also available as stand alone MedCore reports. This allows you to get access to only the cardiac rhythm management market research that you need. You can view all these included reports and segmentation here:

  • Market for ICDs, CRT Devices, Cardiac Leads and Wearable Defibrillators – MedCore
  • Market for Pacemakers and Cardiac Resynchronization Therapy Devices – MedCore

Buying these reports together in this suite package will provide you with substantial discounts from the separate prices. Request Pricing to Learn More

Data Types Included

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • 10 Year Scope and Forecast Range
  • Market Drivers & Limiters for Each  Segment
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors

Cardiac Rhythm Management Market Share Insights

Medtronic leads the way in both the United States and European cardiac rhythm management markets. Medtronic has been able to retain their position in the cardiac rhythm management market through brand recognition, strong customer support and a large sales force. The recall of Medtronic’s defibrillation leads in 2007 did not significantly reduce the company’s market share. In 2011, Medtronic left the external defibrillator market through the sale of their Physio-Control division to Bain Capital.

Other major competitors in the market include Biotronik, Boston Scientific, Abbott and the Sorin Group. Certain companies, such as Boston Scientific, also offer a wide range of electrophysiology (EP) and cardiac ablation products and sell them through large distribution networks.

All Companies Analyzed in this Study

  • B. Braun
  • Biosense Webster
  • Biotronik
  • Boston Scientific
  • C.R. Bard Electrophysiology
  • Cameron Health
  • Cardiac Science
  • CU Medical
  • Defibtech
  • Fukuda Denshi
  • GE Healthcare
  • HeartSine
  • Japan Lifeline
  • Lepu Medical
  • Mediana
  • Medtronic
  • Nanoom Tech
  • Nihon Kohden
  • Oscor
  • Osypka Medical
  • Philips Healthcare
  • Sorin Group
  • St. Jude Medical
  • Vitatron
  • Zoll Medical
For a Full Table of Contents From Any of the Country Reports in this Global Series, please Contact iData

UNITED STATES TABLE OF CONTENTS

LIST OF FIGURES V
LIST OF CHARTS VII
EXECUTIVE SUMMARY 1
1.1 U.S. CARDIAC RHYTHM MANAGEMENT MARKET 1
1.2 TREND ANALYSIS 2
1.3 PACEMAKER MARKET 3
1.4 IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MARKET 4
1.5 CARDIAC RESYNCHRONIZATION THERAPY DEVICE MARKET 5
1.6 CARDIAC LEAD MARKET 6
1.7 COMPETITIVE ANALYSIS 7
1.8 LIST OF PROCEDURAL CODES 8
RESEARCH METHODOLOGY 9
2.1 RESEARCH SCOPE 9
2.2 IDATA’S 9-STEP METHODOLOGY 9
Step 1: Project Initiation & Team Selection 9
Step 2: Prepare Data Systems and Perform Secondary Research 11
Step 3: Preparation for Interviews & Questionnaire Design 12
Step 4: Performing Primary Research 13
Step 5: Research Analysis: Establishing Baseline Estimates 15
Step 6: Market Forecast and Analysis 16
Step 7: Identify Strategic Opportunities 18
Step 8: Final Review and Market Release 19
Step 9: Customer Feedback and Market Monitoring 20

U.S. CARDIAC RHYTHM MANAGEMENT MARKET OVERVIEW


3.1 INTRODUCTION 21
3.2 MARKET OVERVIEW 22
3.3 TREND ANALYSIS 25
3.4 DRIVERS AND LIMITERS 27
3.4.1 Market Drivers 27
3.4.2 Market Limiters 28
3.5 COMPETITIVE ANALYSIS 30
3.6 MERGERS AND ACQUISITIONS 32

PACEMAKER MARKET


4.1 INTRODUCTION 33
4.1.1 Single and Dual Chamber Devices 33
4.1.2 New Technologies 34
4.1.3 Initial Placement and Replacement of Pacemakers 34
4.2 MARKET OVERVIEW 36
4.3 MARKET ANALYSIS AND FORECAST 39
4.3.1 Total Pacemaker Market 39
4.3.2 Total Single-Chamber Pacemaker Market 41
4.3.2.1 Initial Placement Single-Chamber Pacemaker Market 43
4.3.2.2 Replacement Single-Chamber Pacemaker Market 44
4.3.3 Total Dual-Chamber Pacemaker Market 45
4.3.3.1 Initial Placement Dual-Chamber Pacemaker Market 47
4.3.3.2 Replacement Dual-Chamber Pacemaker Market 48
4.3.4 Leadless Pacemaker Market 49
4.4 PRICE ANALYSIS 51
4.5 DRIVERS AND LIMITERS 52
4.5.1 Market Drivers 52
4.5.2 Market Limiters 53
4.6 COMPETITIVE ANALYSIS 54

IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MARKET


5.1 INTRODUCTION 57
5.1.1 Cardiac Resynchronization Therapy-Defibrillators 58
5.2 MARKET OVERVIEW 59
5.3 MARKET ANALYSIS AND FORECAST 62
5.3.1 Total ICD Market 62
5.3.2 Total Single-Chamber ICD Market 64
5.3.2.1 Initial Placement Single-Chamber ICD Market 66
5.3.2.2 Replacement Single-Chamber ICD Market 67
5.3.3 Total Dual-Chamber ICD Market 68
5.3.3.1 Initial Placement Dual-Chamber ICD Market 70
5.3.3.2 Replacement Dual-Chamber ICD Market 71
5.3.4 S-ICD Market 72
5.4 DRIVERS AND LIMITERS 74
5.4.1 Market Drivers 74
5.4.2 Market Limiters 75
5.5 COMPETITIVE ANALYSIS 77

CARDIAC RESYNCHRONIZATION THERAPY DEVICE MARKET


6.1 INTRODUCTION 81
6.1.1 Cardiac Resynchronization Therapy-Pacemakers (CRT-Ps) 81
6.1.2 Cardiac Resynchronization Therapy-Defibrillators (CRT-Ds) 81
6.2 MARKET OVERVIEW 82
6.3 MARKET ANALYSIS AND FORECAST 85
6.3.1 Total CRT Market 85
6.3.2 Total CRT-P Market 87
6.3.2.1 Initial Placement CRT-P Market 89
6.3.2.2 Replacement CRT-P Market 90
6.3.3 Total CRT-D Market 91
6.3.3.1 Initial Placement CRT-D Market 93
6.3.3.2 Replacement CRT-D Market 94
6.4 DRIVERS AND LIMITERS 95
6.4.1 Market Drivers 95
6.4.2 Market Limiters 95
6.5 COMPETITIVE ANALYSIS 98

CARDIAC LEAD MARKET


7.1 INTRODUCTION 101
7.1.1 Replacement of Leads 102
7.2 MARKET OVERVIEW 103
7.3 MARKET ANALYSIS AND FORECAST 106
7.3.1 Total Cardiac Lead Market 106
7.3.2 Pacing Lead Market 108
7.3.3 Defibrillation Lead Market 110
7.3.4 LV Lead Market 112
7.4 DRIVERS AND LIMITERS 114
7.4.1 Market Drivers 114
7.4.2 Market Limiters 114
7.5 COMPETITIVE ANALYSIS 117

APPENDIX: WEARABLE DEFIBRILLATOR DEVICE MARKET


8.1 INTRODUCTION 121
8.2 MARKET ANALYSIS 121

ABBREVIATIONS


PROCEDURAL CODES 125
10.1 LIST OF PROCEDURAL CODES 125


iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology


close-link
close-link

Subscribe to MedTech Market News - Get exclusive analyst articles, monthly newsletters and iData offers

close-link
close-link
close-link